Rangarajan Sanjeet, Hachem Ralph Abi, Ozer Enver, Beer-Furlan Andre, Prevedello Daniel, Carrau Ricardo L
Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Division of Head and Neck Surgery & Communication Sciences, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Otolaryngol Clin North Am. 2017 Jun;50(3):633-641. doi: 10.1016/j.otc.2017.01.013. Epub 2017 Mar 24.
Transoral robotic surgery (TORS) has been proven to be safe and to yield acceptable oncological and functional outcomes for surgery of the oropharynx, hypopharynx, supraglottis, and glottis. TORS has been successful at reducing morbidity, improving quality of life, and providing access to areas that previously required mandibulotomy or other more radical approaches in the past. This has changed the paradigm of management of tumors in these anatomic locations. In this article, the authors review the recent literature discussing the role of robotic surgery in managing sinonasal and skull base pathology and discuss its current advantages and limitations.
经口机器人手术（TORS）已被证明是安全的，并且在口咽、下咽、声门上区和声门手术中能产生可接受的肿瘤学和功能结果。TORS在降低发病率、改善生活质量以及进入过去需要下颌骨切开术或其他更激进方法才能到达的区域方面取得了成功。这改变了这些解剖部位肿瘤的管理模式。在本文中，作者回顾了近期讨论机器人手术在鼻窦和颅底病变管理中作用的文献，并讨论了其当前的优势和局限性。
